Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Cancer Letters
|
February 20, 2013
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
Francesco Fabbri, Silvia Carloni, Wainer Zoli, et al.
Cancers
|
December 24, 2021
CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways
Giulia Gallerani, Tania Rossi, Martina Valgiusti, et al.
Cancer Letters
|
July 18, 2015
Circulating tumor cells in early breast cancer: A connection with vascular invasion
Roberta Maltoni, Pietro Fici, Dino Amadori, et al.
Frontiers in Molecular Biosciences
|
November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer
Erika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Experimental Hematology & Oncology
|
May 6, 2025
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity
Tania Rossi, Sara Bandini, Michele Zanoni, et al.
Cell Death & Disease
|
March 29, 2025
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation
Tania Rossi, Martina Valgiusti, Maurizio Puccetti, et al.
Frontiers in Medicine
|
June 19, 2026
Cancer of unknown primary genomic profiling from cell-free DNA provides insights into CUP biology and vulnerabilities
Roberta Roncarati, Beatrice Fontana, Ilaria Pace, et al.
Ebiomedicine
|
May 7, 2019
Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies
Alberto Visioli, Fabrizio Giani, Nadia Trivieri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
Andrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Cancer Letters
|
February 20, 2013
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
Francesco Fabbri, Silvia Carloni, Wainer Zoli, et al.
Cancers
|
December 24, 2021
CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways
Giulia Gallerani, Tania Rossi, Martina Valgiusti, et al.
Cancer Letters
|
July 18, 2015
Circulating tumor cells in early breast cancer: A connection with vascular invasion
Roberta Maltoni, Pietro Fici, Dino Amadori, et al.
Frontiers in Molecular Biosciences
|
November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer
Erika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Experimental Hematology & Oncology
|
May 6, 2025
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity
Tania Rossi, Sara Bandini, Michele Zanoni, et al.
Cell Death & Disease
|
March 29, 2025
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation
Tania Rossi, Martina Valgiusti, Maurizio Puccetti, et al.
Frontiers in Medicine
|
June 19, 2026
Cancer of unknown primary genomic profiling from cell-free DNA provides insights into CUP biology and vulnerabilities
Roberta Roncarati, Beatrice Fontana, Ilaria Pace, et al.
Ebiomedicine
|
May 7, 2019
Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies
Alberto Visioli, Fabrizio Giani, Nadia Trivieri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
Andrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Page
of 3